Usefulness of p16/ki67 immunostaining in the triage of women referred to colposcopy

Cancer Cytopathology

Volumn 122, Issue 3, 2014, Pages 227-235

  Ordi, Jaume ^a   Sagasta, Amaia ^a   Munmany, Meritxell ^b   Rodríguez Carunchio, Leonardo ^a   Torné, Aureli ^b   Del Pino, Marta ^b  

^a CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Cervical intraepithelial neoplasia; Cytology; Human papillomavirus; P16 Ki67

Indexed keywords

KI 67 ANTIGEN; PROTEIN P16; BIOLOGICAL MARKER; P16 PROTEIN, HUMAN; TUMOR PROTEIN;

ADULT; AGED; CANCER SCREENING; CLINICAL EVALUATION; CLINICAL TRIAL; COLPOSCOPY; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION; HUMAN; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; LOW GRADE SQUAMOUS INTRAEPITHELIAL LESION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DISEASE; WOMEN'S HEALTH; ADOLESCENT; ARTICLE; COMPARATIVE STUDY; EMERGENCY HEALTH SERVICE; EVALUATION STUDY; METABOLISM; METHODOLOGY; MIDDLE AGED; PAPILLOMAVIRUS INFECTION; PATHOLOGY; PATIENT REFERRAL; PRECANCER; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; RISK FACTOR; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX TUMOR; VERY ELDERLY; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CARCINOMA, SQUAMOUS CELL; COLPOSCOPY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MIDDLE AGED; NEOPLASM PROTEINS; PAPILLOMAVIRUS INFECTIONS; PRECANCEROUS CONDITIONS; PROSPECTIVE STUDIES; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TRIAGE; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84899911495     PISSN: 1934662X     EISSN: 19346638     Source Type: Journal    
DOI: 10.1002/cncy.21366     Document Type: Conference Paper

References (32)

1. Arbyn M, Raifu AO, Weiderpass E, Bray F, Anttila A. Trends of cervical cancer mortality in the member states of the European Union. Eur J Cancer. 2009;45:2640-2648
2. Cuzick J, Clavel C, Petry KU, et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer. 2006;119:1095-1101 (Pubitemid 44116919)
3. Ordi J, Alonso I, Torne A, et al. Human papillomavirus load in Hybrid Capture II assay: does increasing the cutoff improve the test? Gynecol Oncol. 2005;99:313-319 (Pubitemid 41502836)
4. The Atypical Squamous Cells of Undetermined Significance/Low- Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. J Natl Cancer Inst. 2000;92: 397-402
5. Cuzick J, Sasieni P, Davies P, et al. A systematic review of the role of human papilloma virus (HPV) testing within a cervical screening programme: summary and conclusions. Br J Cancer. 2000;83:561-565 (Pubitemid 30636292)
6. del Pino M, Torne A, Alonso I, et al. Colposcopy prediction of progression in human papillomavirus infections with minor cervical lesions. Obstet Gynecol. 2010;116:1324-1331
7. Cuzick J, Bergeron C, von Knebel Doeberitz M, et al. New technologies and procedures for cervical cancer screening. Vaccine. 2012;30(suppl 5):F107-F116
8. Galgano MT, Castle PE, Atkins KA, Brix WK, Nassau SR, Stoler MH. Using biomarkers as objective standards in the diagnosis of cervical biopsies. Am J Surg Pathol. 2010;34:1077-1087
9. von Knebel Doeberitz M, Reuschenbach M, Schmidt D, Bergeron C. Biomarkers for cervical cancer screening: the role of p16(INK4a) to highlight transforming HPV infections. Expert Rev Proteomics. 2012;9:149-163
10. Waldstrom M, Christensen RK, Ornskov D. Evaluation of p16(INK4a)/Ki-67 dual stain in comparison with an mRNA human papillomavirus test on liquid-based cytology samples with low-grade squamous intraepithelial lesion. Cancer Cytopathol. 2013; 121:136-145
11. Bergeron C, Ordi J, Schmidt D, Trunk MJ, Keller T, Ridder R. Conjunctive p16INK4a testing significantly increases accuracy in diagnosing high-grade cervical intraepithelial neoplasia. Am J Clin Pathol. 2010;133:395-406
12. Darragh TM, Colgan TJ, Thomas CJ, et al. The Lower Anogenital Squamous Terminology Standardization project for HPVassociated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. Int J Gynecol Pathol. 2013;32:76-115
13. Ordi J, Garcia S, del Pino M, et al. p16 INK4a immunostaining identifies occult CIN lesions in HPV-positive women. Int J Gynecol Pathol. 2009;28:90-97
14. Dijkstra MG, Heideman DA, de Roy SC, et al. p16(INK4a) immunostaining as an alternative to histology review for reliable grading of cervical intraepithelial lesions. J Clin Pathol. 2010;63: 972-977
15. Carozzi F, Cecchini S, Confortini M, et al. Role of P16(INK4a) expression in identifying CIN2 or more severe lesions among HPV-positive patients referred for colposcopy after abnormal cytology. Cancer. 2006;108:119-123
16. Carozzi F, Confortini M, Dalla Palma P, et al. Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: A nested substudy of the NTCC randomised controlled trial. Lancet Oncol. 2008;9:937-945
17. Carozzi F, Gillio-Tos A, Confortini M, et al. Risk of high-grade cervical intraepithelial neoplasia during follow-up in HPV-positive women according to baseline p16-INK4A results: A prospective analysis of a nested substudy of the NTCC randomised controlled trial. Lancet Oncol. 2013;14:168-176
18. Denton KJ, Bergeron C, Klement P, Trunk MJ, Keller T, Ridder R. The sensitivity and specificity of p16(INK4a) cytology vs HPV testing for detecting high-grade cervical disease in the triage of ASC-US and LSIL pap cytology results. Am J Clin Pathol. 2010; 134:12-21
19. Schmidt D, Bergeron C, Denton KJ, Ridder R. p16/ki-67 dual-stain cytology in the triage of ASCUS and LSIL papanicolaou cytology: Results from the European equivocal or mildly abnormal Papanicolaou cytology study. Cancer Cytopathol. 2011;119: 158-166
20. Edgerton N, Cohen C, Siddiqui MT. Evaluation of CINtec PLUS(R) testing as an adjunctive test in ASC-US diagnosed Sure- Path(R) preparations. Diagn Cytopathol. 2013;41:35-40
21. Loghavi S, Walts AE, Bose S. CINtec(R) plus dual immunostain: A triage tool for cervical pap smears with atypical squamous cells of undetermined significance and low grade squamous intraepithelial lesion. Diagn Cytopathol. 2013;47:582-587
22. Petry KU, Schmidt D, Scherbring S, et al. Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16/ Ki-67 dual-stained cytology. Gynecol Oncol. 2011;121:505-509
23. Wentzensen N, Schwartz L, Zuna RE, et al. Performance of p16/ Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population. Clin Cancer Res. 2012;18:4154-4162
24. Zappacosta R, Caraceni D, Ciccocioppo L, et al. Implementing specificity of HPV-DNA primary screening in a successful organised cervical cancer prevention programme. Gynecol Oncol. 2013; 128:427-432
25. Dona MG, Vocaturo A, Giuliani M, et al. p16/Ki-67 dual staining in cervico-vaginal cytology: correlation with histology, Human Papillomavirus detection and genotyping in women undergoing colposcopy. Gynecol Oncol. 2012;126:198-202
26. Walker P, Dexeus S, De Palo G, et al. International terminology of colposcopy: An updated report from the International Federation for Cervical Pathology and Colposcopy. Obstet Gynecol. 2003;101: 175-177 (Pubitemid 36057105)
27. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002;287:2114-2119 (Pubitemid 34437346)
28. Terry G, Ho L, Londesborough P, Cuzick J, Mielzynska-Lohnas I, Lorincz A. Detection of high-risk HPV types by the hybrid capture 2 test. J Med Virol. 2001;65:155-162
29. Stoler MH, Schiffman M. Interobserver reproducibility of cervical cytologic and histologic interpretations: Realistic estimates from the ASCUS-LSIL Triage Study. JAMA. 2001;285:1500-1505 (Pubitemid 32221899)
30. Schiffman M, Wentzensen N. From human papillomavirus to cervical cancer. Obstet Gynecol. 2010;116:177-185
31. del Pino M, Garcia S, Fuste V, et al. Value of p16(INK4a) as a marker of progression/regression in cervical intraepithelial neoplasia grade 1. Am J Obstet Gynecol. 2009;201:488.e1-e7
32. Hariri J, Oster A. The negative predictive value of p16INK4a to assess the outcome of cervical intraepithelial neoplasia 1 in the uterine cervix. Int J Gynecol Pathol. 2007;26:223-228 (Pubitemid 46986053)